A detailed history of Guidance Capital, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Guidance Capital, Inc holds 34,180 shares of PFE stock, worth $976,522. This represents 0.34% of its overall portfolio holdings.

Number of Shares
34,180
Previous 30,725 11.24%
Holding current value
$976,522
Previous $796 Million 31.12%
% of portfolio
0.34%
Previous 0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $87,273 - $102,268
3,455 Added 11.24%
34,180 $1.04 Billion
Q1 2024

Apr 17, 2024

BUY
$25.89 - $29.73 $307,573 - $353,192
11,880 Added 63.04%
30,725 $796 Million
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $98,379 - $127,784
3,765 Added 24.97%
18,845 $560 Million
Q3 2023

Oct 16, 2023

BUY
$32.09 - $37.51 $43,578 - $50,938
1,358 Added 9.9%
15,080 $511 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $495,638 - $573,442
13,722 New
13,722 $495 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Guidance Capital, Inc Portfolio

Follow Guidance Capital, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guidance Capital, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guidance Capital, Inc with notifications on news.